Inhibikase Therapeutics, Inc. (IKT)
NASDAQ: IKT · Real-Time Price · USD
2.310
+0.300 (14.93%)
At close: Nov 22, 2024, 4:00 PM
2.340
+0.030 (1.30%)
After-hours: Nov 22, 2024, 6:39 PM EST
Inhibikase Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 22, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 155 | 8 | 13 | 37 | 69 | - | |
| Market Cap Growth | 30.52% | -37.83% | -65.89% | -46.68% | - | - | |
| Enterprise Value | 152 | -9 | -14 | -8 | 70 | - | |
| Last Close Price | 2.31 | 1.27 | 3.00 | 8.82 | 41.40 | - | |
| PS Ratio | 9703291.00 | 30.10 | 102.18 | 11.93 | 99.29 | - | |
| PB Ratio | -18.29 | 0.71 | 0.60 | 0.96 | 7.09 | - | |
| P/TBV Ratio | - | 0.71 | 0.60 | 0.96 | 7.09 | - | |
| EV/Sales Ratio | 152188066.00 | - | - | - | 100.29 | - | |
| Debt / Equity Ratio | -0.41 | 0.06 | 0.02 | 0.01 | 0.03 | -0.08 | |
| Asset Turnover | - | 0.01 | 0.00 | 0.11 | 0.09 | 0.78 | |
| Quick Ratio | 0.66 | 3.85 | 6.25 | 10.08 | 2.96 | 0.00 | |
| Current Ratio | 0.85 | 4.13 | 6.59 | 10.47 | 3.13 | 0.01 | |
| Return on Equity (ROE) | -270.10% | -118.88% | -60.74% | -61.35% | -107.58% | - | |
| Return on Assets (ROA) | -112.68% | -63.67% | -33.62% | -32.24% | -23.77% | -246.91% | |
| Return on Capital (ROIC) | -167.49% | -76.13% | -37.74% | -37.85% | -58.84% | - | |
| Earnings Yield | -12.61% | -242.67% | -143.13% | -39.99% | -4.11% | - | |
| FCF Yield | -11.11% | -230.82% | -139.49% | -38.66% | -1.63% | - | |
| Buyback Yield / Dilution | -18.14% | -26.28% | -39.15% | -121.72% | -0.39% | -2.08% | |
| Total Shareholder Return | -18.14% | -26.28% | -39.15% | -121.72% | -0.39% | -2.08% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.